Balloon-Occluded Retrograde Transvenous Obliteration versus Transjugular Intrahepatic Portosystemic Shunt for the Management of Gastric Variceal Bleeding
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Gastric varices (GVs) are a major cause of upper gastrointestinal bleeding in patients with liver cirrhosis. The current treatments of choice are balloon-occluded retrograde transvenous obliteration (BRTO) and the placement of a transjugular intrahepatic portosystemic shunt (TIPS). We aimed to compare the efficacy and outcomes of these two methods for the management of GV bleeding. Methods: This retrospective study included consecutive patients who received BRTO (n=157) or TIPS (n=19) to control GV bleeding from January 2005 to December 2014 at a single tertiary hospital in Korea. The overall survival (OS), immediate bleeding control rate, rebleeding rate and complication rate were compared between patients in the BRTO and TIPS groups. Results: Patients in the BRTO group showed higher immediate bleeding control rates (p=0.059, odds ratio [OR]=4.72) and lower cumulative rebleeding rates (logrank p=0.060) than those in the TIPS group, although the difference failed to reach statistical significance. There were no significant differences in the rates of complications, including pleural effusion, aggravation of esophageal varices, portal hypertensive gastropathy, and portosystemic encephalopathy, although the rate of the progression of ascites was significantly higher in the BRTO group (p=0.02, OR=7.93). After adjusting for several confounding factors using a multivariate Cox analysis, the BRTO group had a significantly longer OS (adjusted hazard ratio [aHR]=0.44, p=0.01) and a longer rebleeding-free survival (aHR=0.34, p=0.001) than the TIPS group. Conclusions: BRTO provides better bleeding control, rebleeding-free survival, and OS than TIPS for patients with GV bleeding.
Abstract
Background/Aims: Gastric varices (GVs) are a major cause of upper gastrointestinal bleeding in patients with liver cirrhosis. The current treatments of choice are balloon-occluded retrograde transvenous obliteration (BRTO) and the placement of a transjugular intrahepatic portosystemic shunt (TIPS). We aimed to compare the efficacy and outcomes of these two methods for the management of GV bleeding. Methods: This retrospective study included consecutive patients who received BRTO (n=157) or TIPS (n=19) to control GV bleeding from January 2005 to December 2014 at a single tertiary hospital in Korea. The overall survival (OS), immediate bleeding control rate, rebleeding rate and complication rate were compared between patients in the BRTO and TIPS groups. Results: Patients in the BRTO group showed higher immediate bleeding control rates (p=0.059, odds ratio [OR]=4.72) and lower cumulative rebleeding rates (logrank p=0.060) than those in the TIPS group, although the difference failed to reach statistical significance. There were no significant differences in the rates of complications, including pleural effusion, aggravation of esophageal varices, portal hypertensive gastropathy, and portosystemic encephalopathy, although the rate of the progression of ascites was significantly higher in the BRTO group (p=0.02, OR=7.93). After adjusting for several confounding factors using a multivariate Cox analysis, the BRTO group had a significantly longer OS (adjusted hazard ratio [aHR]=0.44, p=0.01) and a longer rebleeding-free survival (aHR=0.34, p=0.001) than the TIPS group. Conclusions: BRTO provides better bleeding control, rebleeding-free survival, and OS than TIPS for patients with GV bleeding.
참고문헌 (27)
- Nakano R, "Splanchnic hemodynamic pattern and liver function in patients with cirrhosis and esophageal or gastric varices", Am J Gastroenterol, 92, pp.2085~2089 (1997)
- Sarin SK, "Prevalence, classification and natural history of gastric varices: a longterm follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
- de Franchis R, "Natural history of portal hypertension in patients with cirrhosis", Clin Liver Dis, 5, pp.645~663 (2001)
- Triantafyllou M, "Update on gastric varices", World J Gastrointest Endosc, 6, pp.168~175 (2014)
- Wani ZA, "Gastric varices: classification, endoscopic and ultrasonographic management", J Res Med Sci, 20, pp.1200~1207 (2015)
- Girotra M, "Management of gastric variceal bleeding: role of endoscopy and endoscopic ultrasound", World J Hepatol, 6, pp.130~136 (2014)
- Garcia-Tsao G, "Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases", Hepatology, 65, pp.310~335 (2017)
- Kim T, "Risk factors for hemorrhage from gastric fundal varices", Hepatology, 25, pp.307~312 (1997)
- Kahloon A, "Endoscopic therapy with 2-octyl-cyanoacrylate for the treatment of gastric varices", Dig Dis Sci, 59, pp.2178~2183 (2014)
- ASGE Technology Committee, "Tissue adhesives: cyanoacrylate glue and fibrin sealant", Gastrointest Endosc, 78, pp.209~215 (2013)
- Berry PA, "Clinical challenges and images in GI: pulmonary embolization of histoacryl “glue” causing hypoxia and cardiovascular instability", Gastroenterology, 133, pp.1413~1748 (2007)
- Saracco G, "Fatal multiple systemic embolisms after injection of cyanoacrylate in bleeding gastric varices of a patient who was noncirrhotic but with idiopathic portal hypertension", Gastrointest Endosc, 65, pp.345~347 (2007)
- Türler A, "Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate", Gastrointest Endosc, 53, pp.228~230 (2001)
- Chang CJ, "Management of acute gastric varices bleeding", J Chin Med Assoc, 76, pp.539~546 (2013)
- Olson JC, "Gastrointestinal issues in liver disease", Crit Care Clin, 32, pp.371~384 (2016)
- Fukui H, "Evidence-based clinical practice guidelines for liver cirrhosis 2015", J Gastroenterol, 51, pp.629~650 (2016)
- Saad WE, "Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices", Semin Intervent Radiol, 28, pp.339~349 (2011)
- 김문영, "Clinical features and outcomes of gastric variceal bleeding: retrospective Korean multicenter data", Clinical and Molecular Hepatology, 19(1), pp.36~44 (2013), 대한간학회[DOI]
- Wang YB, "Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: a meta-analysis", J Gastroenterol Hepatol, 31, pp.727~733 (2016)
- Park JK, "Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis", Dig Dis Sci, 60, pp.1543~1553 (2015)
- 장세영, "Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study", Clinical and Molecular Hepatology, 18(4), pp.368~374 (2012), 대한간학회[DOI]
- 최영호, "Balloon-Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleeding:Its Feasibility Compared with Transjugular Intrahepatic Portosystemic Shunt", Korean Journal of Radiology, 4(2), pp.6~116 (2003), 대한영상의학회
- Ninoi T, "TIPS versus transcatheter sclerotherapy for gastric varices", AJR Am J Roentgenol, 183, pp.369~376 (2004)
- Lee SJ, "Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis", J Gastroenterol Hepatol, 32, pp.1487~1494 (2017)
- Saad WE, "Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes", Semin Intervent Radiol, 29, pp.118~128 (2012)
- Kato T, "Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis", Intern Med, 40, pp.688~691 (2001)
- Kumamoto M, "Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome", J Gastroenterol Hepatol, 25, pp.1129~1135 (2010)